READ-OUT – REAl world Dementia OUTcomes: Observational Study

A dementia diagnosis from a memory clinic currently tells you *that* someone has the condition, but not reliably *what kind* or *how fast* it will progress. The problem is that existing diagnostic tools—interviews, memory tests, and brain scans—are blunt instruments for predicting a patient’s future. Blood tests could change this, but the research done so far has mostly studied people who are white, healthy, and relatively young—not the real mix of patients seen in NHS memory clinics. The READ-OUT study will test blood-based biomarkers in thousands of people across UK memory clinics, deliberately recruiting from groups often left out of research: the very elderly, ethnic minorities, people in deprived areas, and those with multiple illnesses. If these blood tests prove accurate and cost-effective in this real-world population, they could give clinicians a cheap, fast way to distinguish Alzheimer’s from other dementias and forecast how the disease will unfold. For the NHS, that could mean fewer unnecessary scans, earlier access to the right treatments, and better planning for care—all without requiring expensive hospital equipment. The project will also assess whether the tests are good value for money, a crucial step before any rollout.